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Summary
Dendritic cells process internalized antigens to pres-
ent degradative products onMHC for TCR recognition.
Because antigen-exposed DCs also induce humoral
immunity, DCs must also retain antigen in its native
state for the engagement of BCR on B cells. Here, we
demonstrate that antigen endocytosed by the inhibi-
tory Fc receptor, FcgRIIB, accesses a nondegradative
intracellular vesicular compartment that recycles to
the cell surface, enabling interaction of native antigen
withBCRonBcells. Immunizationwith IgG-opsonized,
T independent antigens leads to enhanced humoral re-
sponses in a FcgRIIB and complement dependent
manner. IC-loaded DCs trafficking to the splenic mar-
ginal zone can prime a T independent response in an
FcgRIIB-dependent manner. Thus dendritic cells are
equipped with both nondegradative and degradative
antigenuptake pathways to facilitate antigenpresenta-
tion to both B and T cells.
Introduction
It has been well established that dendritic cells (DCs)
play pivotal roles in tolerance and the initiation of cellular
and humoral immune responses (Steinman et al., 2003).
In particular, the mechanisms through which DCs prime
naı¨ve T cells have been extensively studied (Guermon-
prez et al., 2002; Trombetta and Mellman, 2005). In con-
trast, the role that DCs may play in the priming of B cells
is less well understood, especially in the context of a T
independent immune response. B cells may encounter
antigen as either free antigen or as carried by DCs (Ba-
lazs et al., 2002), the latter scenario enabling B cells to
be influenced by activation signals provided by DCs, in-
cluding TNF-family members (MacLennan and Vinuesa,
2002; Macpherson and Lamarre, 2002) and cytokines
(Balazs et al., 2002; Dubois et al., 1998; Jego et al.,
2003; Poeck et al., 2004). The ability of DCs to induce hu-
moral responses (Wykes et al., 1998) suggests that
dendritic cells have an antigen-retention compartment
accessible for BCR engagement on B cells. Indeed, re-
cent work indicates that DCs have a specialized capac-
ity for the retention of antigen (Delamarre et al., 2005) in-
cluding microbes (Macpherson and Uhr, 2004; Niess
et al., 2005), but the provision of this antigen for B cell
priming has not been addressed.
*Correspondence: rc645@columbia.eduImmature DCs act as sentinels in the periphery and are
exceptionally adept at antigen capture and processing
via an array of uptake receptors that recognize molecular
motifs associated with pathogens or components of the
innate and adaptive immune system, including comple-
ment and immunoglobulin. In particular, uptake of im-
mune complexes (ICs) by the activating FcgRs, FcgRI,
and FcgRIII, facilitates T cell priming by targeting effi-
cient entry into the lysosome, allowing for availability of
peptide determinants for loading onto both MHC I and
II molecules. In transfected B cells and mast cells, lyso-
somal targeting and efficient antigen degradation is de-
pendent on recruitment of the tyrosine kinase syk to
the phosphorylated ITAM within the FcR-associated g
chain (Amigorena et al., 1998; Bonnerot et al., 1998),
whereas simple internalization of ICs does not require
either syk or an intact ITAM. Engagement of activating
FcRs also triggers DC cellular activation/maturation in
a syk (Sedlik et al., 2003) and g chain-dependent manner
(Regnault et al., 1999) and is inhibited by coligation of the
opposing inhibitory Fc receptor, FcgRIIB (Ravetch and
Bolland, 2001). Thus, ITAM-mediated signaling in DCs
couples efficient degradation of internalized ICs with cel-
lular maturation, generating potent CD4 (Amigorena
et al., 1992b; Bonnerot et al., 1998) and CD8 responses
(Kalergis and Ravetch, 2002; Rafiq et al., 2002; Regnault
et al., 1999; Schuurhuis et al., 2002).
Endocytosis of ICs by FcgRIIB is mediated by the di-
leucine motif in the cytoplasmic tail of the isoform
FcgRIIB2, whereas the presence of an inserted se-
quence in the FcgRIIB1 isoform prevents endocytosis
(Miettinen et al., 1992, 1989). The functional consequen-
ces of ICs internalized by the inhibitory receptor FcgRIIB
on APCs is less clearly defined. Prior studies in APCs
have demonstrated that multivalent ligand (but not mo-
nomeric ligand) induces internalization and lysosomal
degradation of the ligand and receptor (Ukkonen et al.,
1986). However, in these studies activating and inhibi-
tory Fc receptors were not distinguished. In transfection
systems, only a subset of potential MHC II-restricted
T cell epitopes are efficiently presented after uptake
via FcgRIIB, whereas a complete repertoire of potential
T cell epitopes are presented after uptake via activating
Fc receptors (Amigorena et al., 1998). This suggests the
existence of a degradative pathway accessed by FcgRIIB
distinct from that accessed by activating Fc receptors.
We demonstrate two distinct functional antigen pro-
cessing pathways accessed by activating and inhibitory
FcgRs on DCs. Contributions of FcgRs to the T indepen-
dent (TI-2) antigen DNP-ficoll humoral response were
examined, thus eliminating activating FcgR-mediated
effects on T cell help. Immunization of mice with TI-2
ICs demonstrates that opsonizing antibodies can en-
hance a humoral response. This enhancement by anti-
body does not occur in FcgRIIB2/2 or in chimeric mice
that have FcgRIIB deleted only on myeloid cells. To de-
termine whether FcgRIIB is required on DCs, we exam-
ined mice adoptively transferred with DCs pulsed with
TI-2 ICs and show that only DCs that express FcgRIIB
are capable of inducing a TI-2 response. Given the
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other myeloid APCs, we set out to determine the fate
of antigen-antibody complexes endocytosed through
FcgRIIB on DCs. We show that ICs taken up through
FcgRIIB are inefficiently degraded and do not reach
a LAMP-1+ vesicular compartment but are instead de-
tected intracellularly in recycling endosomes as well as
on the cell surface. This trafficking pattern of ICs after in-
ternalization by FcgRIIB on DCs can activate B cells to
proliferate in vitro in the presence of an antibody to
CD40, demonstrating a likely mechanism for FcgRIIB-
dependent antibody enhancement of TI-2 humoral re-
sponses in vivo.
Recent work has established that dendritic cells traffic
to extrafollicular areas (Garcia De Vinuesa et al., 1999)
and the splenic marginal zone (Balazs et al., 2002) and
can facilitate B cell activation through the generation of
TNF-family members, Blys, and/or APRIL and via cyto-
kines. Yet this supportive role for DCs has not included
a mechanism for delivery of antigen for BCR engage-
ment. We have identified an antigen-retention compart-
ment accessible by recycling FcgRIIB receptors en-
abling DC to internalize, store, and recycle antigen for
the direct presentation of native antigen to B cells.
Results
IC Enhancement of the T Independent Response
Is Mediated by FgRIIB In Vivo
To examine the contributions of Fcg receptors and com-
plement in antibody-mediated enhancement of the T in-
dependent humoral response, wt, FcgRg2/2 (deficient in
the expression of thegchain, required for signaling of the
activating IgG receptors FcgRI, III) or FcgRIIB2/2 mice
were immunized intraperitoneally with the type 2 T inde-
pendent (TI-2) antigen DNP-ficoll or IgG1-opsonized
DNP-ficoll (DNP-ficoll/ICs) in the presence or absence
of complement depletion. DNP-ficoll is known to bind
components of the complement system directly, in par-
ticular C3d. Complement and CR1/2 deficient mice ex-
hibit reduced humoral responses, including IgG3 re-
sponses (Haas et al., 2002), to T independent antigens
perhaps due to loss of IC/Ag binding to marginal zone
B cells and loss of CD19/21 coreceptor signaling (Guina-
mard et al., 2000; Pozdnyakova et al., 2003). Consistent
with these prior data, complement reduced both IgM
and IgG3 responses although the reduction in IgG3 re-
sponse to both DNP-Ficoll alone and ICs was more dra-
matic (Figure S1). Regardless of complement status, IgM
and IgG3 responses were surprisingly lower in IC-immu-
nized FcgRIIB2/2 than in IC-immunized wt mice or g2/2
mice (Figure 1). These data contrast with the known en-
hancement of T dependent humoral responses in
FcgRIIB-deficient mice previously attributed to loss of
ITIM-mediated inhibition of BCR signaling and/or facili-
tated T cell help due to unbridled IC-mediated APC acti-
vation (Getahun et al., 2004; Wernersson et al., 1999).
To eliminate contributions of FcgRIIB expressed on B
cells (Minskoff et al., 1998) in the humoral response to TI-
2/ICs, RAG2/2 BM chimeric animals were generated af-
ter transfer of wt bone marrow into sublethally irradiated
RAG2/2 wt or FcgRIIB2/2 recipients. Thus, all RAG2/2
BM-reconstituted chimeras contained a wt lymphoid
(B cell) compartment, whereas the nonlymphoid com-partment, including the myeloid (APC) recipient com-
partment, remained predominantly host derived, either
wt or FcgRIIB2/2, as assessed by allotypic marker sta-
tus of peritoneal macrophages (Figure S3). As seen in
Figures 1E and 1F, IC enhancement of both IgM and
IgG3 responses required expression of FcgRIIB in the
nonlymphoid compartment. Thus, FcgRIIB expression
on non-B cells, presumably myeloid-derived APCs, is
required for the IC-enhancement of T independent hu-
moral response.
ICs Internalized by FcgRIIB on DCs Can Trigger
T Independent Responses
Given their importance in mediating antigen presenta-
tion of endocytically acquired antigens to T cells, we ex-
amined whether IC-loaded DCs could also participate in
priming of B cells by soluble antigen. The humoral re-
sponse to a T dependent antigen was examined first. Up-
take of ICs through activating FcgRs on DCs induces po-
tent T cell responses in vivo due to efficient access of the
exogenous antigen processing pathway, coupled with
the induction of ITAM-triggered maturation. In models
of IC-triggered inflammatory responses, the threshold
of cellular activation is determined by the level of expres-
sion of the opposing activating versus inhibitory FcgRs
on cells of the innate immune system. Similarly the ability
of DCs to activate T cell responses is attenuated by the
presence of FcgRIIB (Kalergis and Ravetch, 2002). In ac-
cord with this paradigm, when mice were immunized with
FcgRIIB2/2 DCs pulsed with OVA-ICs, a model T depen-
dent antigen, OVA-specific IgG1 titers were significantly
higher than titers in mice immunized with wt DCs (Figure
2A). Thus, antibody-mediated enhancement of T depen-
dent humoral responses is likely due to DC expression of
opposing activating and inhibitory FcRs, which modu-
late IC-facilitated antigen presentation to T cells.
In contrast to the T dependent humoral response,
mice immunized with DCs pulsed with DNP-ficoll/ICs
mounted a robust antigen-specific antibody response
only if the DCs express FcgRIIB (Figures 2B and 2C).
Antigen-specific responses were induced of both the
IgM and IgG3 isotype, suggesting that antigen provided
by DCs is sufficient for the activation of B cells and in-
duction of Igh class-switching in a T independent man-
ner (Figure 2D). DCs pulsed with DNP-ficoll alone did
not induce appreciable antibody responses (Figures
2B and 2C). In order to determine whether complement
plays a role in enabling FcgRIIB-expressing DCs to stim-
ulate B cell responses, we injected wt DCs pulsed with
DNP-ficoll ICs into C3-deficient hosts and measured
the IgM and IgG3 responses. IgM responses were com-
parable in C3-deficient and wt animals, yet the IgG3
responses were significantly diminished in C32/2 mice
(Figures 2E and 2F), showing that complement contrib-
utes to the induction of class-switching triggered by
IC-bearing DCs.
The ability of ICs acquired through FcgRIIB on DCs to
induce T independent humoral responses is likely due to
trafficking of IC-loaded injected DCs not only to T cell
areas but also to the marginal zone and red pulp (Figure
S4A), where encounters with marginal zone B cells are
likely to occur. Five days after immunization, extensive
expansion of l-bearing, DNP-specific plasmablasts
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505Figure 1. Humoral Responses to Immunization with DNP-Ficoll/ICs Requires FcgRIIB on Nonlymphoid Cells
(A–D) TI-2 immunizations. Wt, FcgRIIB2/2, or g2/2 mice were immunized i.p. with DNP-ficoll or DNP-ficoll ICs and sera collected on day 7. Each
circle represents an individual mouse. IC-enhanced responses were seen for all wt groups (IC versus Ag; p = 0.09, 0.0005, 0.036, and 0.01 for [A],
[B], [C], and [D], respectively). In all situations, titers in FcgRIIB2/2 IC-immunized mice were dramatically reduced. (A) and (B) show antigen-
specific IgM and IgG3 in mice with intact complement systems (***p < 0.0001, *p = 0.02 and 0.03 from left to right). (C) and (D) show antigen-
specific IgM and IgG3 in CVF-treated mice. (*p = 0.03, ***p < 0.0001 in (C) and *p = 0.01in D, nsp = 0.14). Dashed lines represent the background
OD obtained with naive C57Bl/6 serum.
(E and F) TI-2 immunizations of chimeric mice. CVF-treated reconstituted RAG chimeric mice containing a wt lymphoid compartment were im-
munized as described in (C and D). ELISA data of DNP-specific IgM (E) or IgG3 (F) shows that enhanced antibody responses to DNP-ficoll ICs
requires FcgRIIB expression in recipient RAG2/2 (nonlymphoid) cells (**p = 0.0019 and ***p = 0.0006, respectively).(Jacob and Kelsoe, 1992) containing high levels of cyto-
plasmic IgM were seen in the red pulp (Figure S4B).
ICs Endocytosed through FcgRIIB Are Retained
in Their Native Form
Because humoral responses in IC-loaded DC immunized
mice required FcgRIIB, this suggested that antigens in-
ternalized through FcgRIIB, as opposed to activating
FcgRs, might be preferentially retained and protected
from ITAM-mediated degradation. To distinguish be-
tween the role of activating and inhibitory FcRs in DCs,
primary bone-marrow-derived dendritic cells (BMDCs)
were prepared from wt, g2/2, or FcgRIIB2/2mice. Rates
of internalization were similar through either activating or
inhibitory Fc receptors, with the majority of total internal-
ized ICs internalized within the first 15 min of the incuba-
tion period (Figure 3C). However, the fate of internalized
complexes was strikingly different. Pulse-chase analysis
of OVA-IC trafficking revealed that by 2 hr, ICs are unde-
tectable after uptake through activating FcgRs, whereas
ICs endocytosed by g2/2DCs through FcgRIIB were de-
tectable throughout the 90 min chase period and remain
detectable for up to 48 hr (Figure 3A and data not shown).
Wt DCs express all three FcgRs (Kalergis and Ravetch,
2002; Tan et al., 2003; data not shown) and showed an in-
termediate level of fluorescence (Figure 3A).
To confirm that ICs endocytically acquired through
FcgRIIB were excluded from the lysosomal degradativepathway, colocalization studies of internalized ICs with
the lysosomal marker LAMP-1 were performed (Figure
4A). ICs entering through the activating pathway distrib-
uted to the LAMP-1-positive lysosomal compartments,
whereas uptake via inhibitory Fc receptors leads to a pe-
ripherally distributed LAMP-1 negative compartment.
Consistent with these distinct routes of antigen degrada-
tion versus retention, OVA/IC pulsed wt or FcgRIIB2/2
BMDCs induced robust T cell activation of MHC-II re-
stricted OVA-specific OT II hybrids, whereas OVA/IC
pulsedg2/2BMDCs poorly induced T cell activation (Fig-
ure 4B). In maturing DCs, the proteolytic activity of the
endolysosomal compartment is enhanced by the activity
of the ATP-dependent vacuolar proton pump (V-ATPase)
and is inhibitable by the pH-elevating drug chloroquine
(Trombetta et al., 2003). As expected, chloroquine in-
hibited the degradation of ICs internalized via activating
Fc receptors but had no effect on the stability of ICs
entering via FcgRIIB (Figure 4C). Thus, ICs internal-
ized through FcgRIIB on BMDCs enter a chloroquine-
insensitive compartment that poorly localizes with the
lysosomal marker LAMP-1 and weakly accesses the ex-
ogenous antigen processing pathway.
FcgRIIB Internalized ICs Are Recycled
to the Cell Surface
Engagement of BCR on interacting B cells requires
BCR access to antigen, presumably on the surface of
Immunity
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sponses In Vivo
(A–C) T dependent and -independent humoral responses. Wt C57Bl/6 mice were immunized subcutaneously with 13 106 wt, FcgRIIB2/2, or g2/2
DCs pulsed with OVA or OVA-ICs (A), or were immunized i.v. with DCs pulsed with the TI-2 antigen DNP-ficoll or DNP-ficoll ICs (B and C). ODs of
ELISAs detecting antigen-specific IgG or IgM using diluted sera obtained on day 14 (A) and day 5 (B and C) are shown, respectively (**p = 0.0066
and ***p < 0.0001).
(D–F) Augmented IgG3 responses in mice after immunization with FcgRIIB expressing DCs pulsed with DNP-ficoll ICs requires host complement,
but not T, cells. (D) TCRbd2/2mice were immunized i.v. with wt, FcgRII2/2, org2/2DCs pulsed with DNP-ficoll ICs or DNP-ficoll alone. ODs of DNP-
specific IgM and IgG3 ELISAs using diluted sera obtained on day 7 are shown. (*p = 0.045 and nsp = 0.07) (E and F) wt mice or C32/2 recipient mice
were immunized i.v. with wt DCs pulsed with DNP-ficoll ICs. ODs of DNP-specific IgM and IgG3 ELISAs using diluted sera obtained on day 7 are
shown (nsp = 0.24 and ***p = 0.001).IC-loaded DCs. Although previous studies have shown
that FcRs can recycle back to the plasma membrane af-
ter binding of monomeric ligand (Ukkonen et al., 1986), it
has not yet been demonstrated that their immune com-
plex cargo can also be recycled to the cell surface. Using
a cell-based ELISA (Figure 5A), both the total amount of
cell-associated and surface antigen on dendritic cells
were independently measured after incubation with
ICs. Uptake through the activating Fc receptors (by
FcgRIIB2/2 DCs) leads to a degradative compartment,
and thus, no cell surface antigen is detectable after a
24 hr pulse-chase IC incubation. In striking contrast,
after uptake through the inhibitory FcgRIIB, >0.7 ng of
antigen/106 cells remained cell-associated antigen,most or all of which was on the cell surface. After incu-
bation of ICs with wt DCs (which express both activating
and inhibitory FcRs), >0.4 ng antigen/106 cells remained
cell associated of which a significant portion (>0.16 ng)
was detectable on the cell surface. Thus FcgRIIB-bear-
ing DCs retain both intracellular and cell-surface-associ-
ated antigen for more than 24 hr. Similar results were
obtained after a 90 min pulse-chase period using
immunoflourescent detection of surface-bound ICs
(Figure S5A).
To confirm that ICs were entering the DC prior to cell
surface recycling, as opposed to never being internal-
ized, the cell surface was stripped of detectable ICs
and then incubated to allow for the reaccumulation of
ICs Recycled by FcgRIIB on DCs Activate B Cells
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(A and B) Retention of ICs after internalization through FcgRIIB. Pulse chase of wt, FcgRIIB2/2, andg2/2DCs with OVA-ICs. At the indicated times
cell-associated ICs (green) were detected in fixed, permeabilized cells and the mean percentage of fluorescent cells is represented graphically
in (B). One of five similar experiments is shown. OVA was not detected in DCs pulsed with uncomplexed OVA at any chase period (data
not shown). ICs internalized through FcgRII are retained for >2 hr whereas ICs internalized through activating FcRs are 80% degraded by 30 min.
**p = 0.002, ***p = 0.0002.
(C) Activating and inhibitory FcgR internalizaton rates. The percentage of surface ICs internalized by FcgRIIB2/2 (6) or g2/2 (B) or wt (,) BMDCs
was determined over time (internalized ICs at 37ºC [experimental]/ICs bound at 4ºC [standard]3 100). Percentages greater than 100 were reached
because fluorescent ICs were continually present and thus accumulated during the pulse period. One of three representative experiments are
shown. Uptake rates are similar at the 15 min time point, with 65%, 61%, and 86% of maximal internalization (achieved at 120 min) reached by
wt, FcgRIIB2/2, and g2/2 DCs respectively.recycled ICs onto the cell surface. For this detection
process, cells were first pulsed with biotinylated ICs
for 10 min at 4ºC and then chased for 1 hr at 37ºC.
Only cells lacking activating FcRs demonstrated promi-
nent surface biotin staining after a 1 hr chase (Figure 5D),
consistent with our prior results with nonbioinylated ICs.
Biotinylated molecules were then removed from the cell
surface while leaving internalized biotinylated com-
plexes intact, with the use of a cell-impermeable reduc-
ing agent, MESNA, to disrupt the biotin disulfide linkage.
The stripping procedure resulted in a 75% decrease in
detectable surface ICs (Figure 5D). No surface staining
accumulated during the chase period in cells expressing
activating FcgRs, confirming their failure to recycle anti-
gen to the cell surface. In contrast after reincubation of
g2/2 IC pulsed BMDCs, stripped cells reaccumulated bi-
otinylated ICs on the cell surface, confirming that the
pool of surface bound ICs results from recycling inter-
nalized stores.
In support of the recycling capabilities of FcgRIIB,
a recycling inhibitor, primiquine (van Weert et al.,
2000), was found to reduce IC detection on the cell sur-face in a dose-dependent manner (Figure 5C). Mainte-
nance of cell surface binding of ICs is therefore not
due to lack of internalization but, rather, required recy-
cling, since it was abrogated by inhibitors of exocytosis
and indeed could be replenished from intracellular
stores. The data demonstrating recycling of FcgRIIB
are consistent with a prominent role for FcgRIIB2 on
DCs as opposed to the nonendocytic FcgRIIB1 isoform.
FcgRIIB1 is expressed on B cells and other cell types
(Amigorena et al., 1992a; Miettinen et al., 1989; Minskoff
et al., 1998; Stuart et al., 1989) but poorly by cultured
DCs (Figure S5B).
ICs Recycled by FcgRIIB Can Activate B Cells
To directly demonstrate functional B cell activation by
recycling ICs, we utilized an IC composed of a surrogate
ligand for BCR, a goat anti-IgM F0(ab)2 fragment, com-
plexed with a secondary rabbit whole anti-goat Ig.
Washed IC-pulsed DCs were cocultured with polyclonal
splenic B cells. In the first 8 hr after coincubation, DC/B
cell conjugates were observable but only when using IC-
pulsed FcgRIIB-bearing g2/2 BMDCs (Figure 6A and
Immunity
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(A) Confocal analysis of LAMP-1 and IC colocalization. OVA-IC pulsed BMDCs were stained to detect ICs (green) and LAMP-1+ lysosomes (red). 5
min, 30 min, and 2 hr chases were examined at 630x. Colocalization of ICs endocytosed by FcgRIIB2/2, but not g2/2, with LAMP-1 is apparent.
The colocalization pattern of ICs with LAMP-1of wt DCs shows both characteristics.
(B) ICs internalized through FcgRIIB on BMDCs poorly access the exogenous antigen processing pathway. BMDCs were incubated with OVA
or OVA-ICs and cocultured with OT II T cell hybridomas. Wt and FcgRIIB2/2 showed dramatic IC-mediated enhancement of MHC-II restricted
antigen presentation, inducing comparable T cell activation capacity at 1000-fold reduced ovalbumin concentrations. In contrast g2/2
BMDCs showed only modest IC-enhancement (<10-fold) of antigen presentation compared with equivalent concentrations of non-complexed
ovalbumin.
(C) Chloroquine inhibits degradation of ICs internalized by activating, but not inhibitory, FcRs. Fixed, permeabilized cells were stained after a 2 hr
IC pulse, to detect nondegraded cell-associated ICs, with or without chloroquine pre-treatment, an inhibitor of vesicular acidification. Chloro-
quine prevented degradation of ICs acquired through activating Fc receptors (*p = 0.038 and **p = 0.0021) but had little effect on ICs internalized
through FcgRIIB. One of two similar experiments is shown.Figure S6A). Under these culture conditions, IC-loaded
g2/2 DCs stimulated B cells to upregulate the early acti-
vation marker CD86 (Figure S6B) and to proliferate in the
presence of an antibody to CD40, as a surrogate for T
cell help (Figure 6B). In contrast wt and FcgRIIB2/2
DCs were unable to stimulate B cell proliferation beyond
that seen with unpulsed DCs and anti-CD40 alone, dem-
onstrating that uptake via the ITAM-mediated pathway
failed to promote DC activation of B cells in vitro. Coin-
cubation of g2/2 DCs with agonistic CD40 antibody was
required for the proliferative effects; IC-pulsed g2/2BMDCs cultured in the absence of a-CD40 promoted
B cell death consistent with BCR-mediated activation
induced cell death (Figure S6C). Thus, recycled ICs in-
ternalized through FcgRIIB on DCs remain accessible
to neighboring B cells in a conformationally native state
enabling BCR engagement.
Discussion
DCs are recognized for their capacity to degrade and
process antigen for the priming of T cell responses,
ICs Recycled by FcgRIIB on DCs Activate B Cells
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(A) Quantitative retention of internalized and cell surface ICs requires FcgRIIB. Detection of cell-associated OVA was performed by cell-based
ELISA after a 24 hr pulse of BMDCs with OVA (white bars) or OVA-ICs (black bars). One of three representative experiments is shown. Data points
show the mean 6 SEM of duplicate determinations.
(B) Persistence of surface ICs internalized by FcgRIIB is reduced by the recycling inhibitor primiquine. OVA/IC pulsed g2/2 BMDCs were
assayed for their ability to recycle ICs to the cell surface in the presence of increasing doses of primiquine.
(C) FcgRIIB internalized ICs reaccumulate on the cell surface. g2/2 (black bars) or FcgRIIB2/2 DCs (white bars) were assayed for reaccumu-
lation of OVA-biotin-ICs on the cell surface 14 hr after stripping with MESNA. One of two representative experiments is shown.but DCs must also be endowed with the ability to trans-
port and retain conformationally intact antigen enabling
BCR engagement and humoral immunity (Wykes et al.,
1998). Recent work has suggested that DCs are special-
ized for antigen retention (Delamarre et al., 2005), en-
abling delivery of microbes from the intestinal lumen to
secondary lymphoid structures (Macpherson and Uhr,
2004; Niess et al., 2005) permitting antigenic persistence
after internalization by migrating DCs.
Although numerous DCs are found in T cell areas of
lymphoid organs, they are also present and interacting
with B cells in lymph (Kushnir et al., 1998), follicular
areas (Berney et al., 1999; Lindquist et al., 2004), the
marginal zone (Balazs et al., 2002), and the red pulp
(Garcia De Vinuesa et al., 1999). Migrating and/or resi-
dent DCs could possibly contribute to antigen trapping
and delivery for B cell activation in the T dependent
and -independent antibody response. Several DC types
have been described that might bind and/or transport
antigen for the presentation to follicular B cells, includ-
ing germinal center DCs (Grouard et al., 1996), CXCR5-
expressing dermal-derived DCs (Saeki et al., 2000; Wu
and Hwang, 2002), and CR-positive DCs (Berney et al.,
1999). In a model T independent response, Balazs and
coworkers showed that DCs carrying blood-borne bac-teria initiated the humoral response by engaging re-
sponding antigen-specific B cells in the bridging chan-
nels of the splenic marginal zone. This DC-triggered T
independent response could be blocked with soluble
TACI, demonstrating a requirement for the ligands Blys
and/or APRIL. Dendritic cells may also provide survival
factors for the extrafollicular phase of plasmablast de-
velopment (Garcia De Vinuesa et al., 1999; MacLennan
et al., 2003). Myeloid or plasmacytoid dendritic cells
can provide support for B cell differentiation in vitro in
the absence of T cell help, but curiously these systems
have used either no antigen (Dubois et al., 1997) or an
exogenous BCR crosslinking agent intended to directly
activate B cells (Jego et al., 2003; Poeck et al., 2004).
Thus DCs can provide B-cell-tropic activation signals,
but the manner in which a native antigen BCR signal is
delivered is unclear. We show here that internalized an-
tigen can be recycled to the cell surface for provision of
signal 1 to B cells.
In vivo studies in which mice were directly immunized
with ICs containing T independent antigens (Figure 1)
demonstrate that IC-mediated enhancement of T inde-
pendent humoral responses requires FcgRIIB in vivo on
non-B cells. Although this notion apparently conflicts with
preexisting paradigms that ICs enhance T dependent
Immunity
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(A) DC:B cell conjugate formation. BMDCs were pulsed overnight with anti-IgM containing ICs. Conjugates were then allowed to form between
CFSE-labeled B cells and washed DCs. Conjugates did not form between unpulsed DCs and B cells (data not shown) but were readily seen with
IC-pulsed g2/2 BMDCs.
(B) B cell proliferation responses. BMDCs were either pulsed (shaded histogram) or unpulsed (black line overlay) overnight with anti-IgM ICs,
washed, and then cocultured with CFSE labeled B cells. On day 3 proliferation of B cells was assessed by gating for size and lack of CD11c ex-
pression. Representative data of three similar experiments is shown. In the absence of dendritic cells, B cells cultured with soluble anti-IgM ICs (5
mg/ml anti-IgM) were induced to proliferate (inset). B cells cocultured with unpulsed DCs and anti-CD40 induced some proliferative B cell re-
sponses (black lines). Proliferative B cell responses were dramatically enhanced with IC-pulsed g2/2 DCs, but not by DCs expressing activating
FcgRs.humoral responses through activating Fc receptors, the
data are consistent with the functional roles of CR1 and
FcgRIIB expressed by follicular dendritic cells (Bar-
rington et al., 2002; Fang et al., 1998; Qin et al., 2000).
We demonstrate that antigen endocytosed through
FcgRIIB is internalized into a recycling vesicular system,
largely excluded from the LAMP-1+ degradative com-
partment. Antigenic persistence is long lived, lasting
more than 48 hr, suggesting that antigen acquired in
the periphery by migrating DCs would be available for
activation of lymphocytes in secondary lymphoid struc-
tures. Recycling ICs on the cell surface are able to inter-
act with BCR on B cells, a functional interaction that
requires conformationally intact antigen. Proliferative
B cell responses occur after DC/B cell conjugate for-
mation in vitro and after injection of DNP-ficoll/IC-loaded
BMDCs induced T independent humoral responses
in vivo.
It remains to be seen whether other adsorptive endo-
cytosis receptors can recycle internalized antigen for B
cell priming. An interesting candidate is the neonatal
Fc receptor, FcRn, which exhibits pH-dependent extra-
cellular dissociation of ligand and is responsible for IgG
homeostasis and transport of both unbound IgG (Dick-
inson et al., 1999; Story et al., 1994; Yoshida et al.,
2004) and IgG/ICs (Yoshida et al., 2004). Other endocytic
receptors, including the mannose receptor (Mahnkeet al., 2000), are internalized into a peripheral endosomal
compartment that does not colocalize to the lysosome
and remains cell-associated for hours. Although it has
not yet been shown that the mannose receptor recycles
to the cell surface with its internalized ligand, human
DC-SIGN has been shown to recycle to the surface, car-
rying as cargo intact HIV virions with preserved infectiv-
ity for the trans-fection of T cells (Kwon et al., 2002).
The data support a model (Figure 7) in which the
two complementary FcR pathways enable antibody-
enhancement of B/T lymphocyte activation by together
providing a degradative route for MHC-loading/T cell
activation and a retention pathway for preservation of
conformationally intact antigen for B cell activation.
Thus the two pathways act in a parallel fashion, in which
activating FcRs provide enhancement for the generation
of T cell epitopes while FcgRIIB enables preservation
and concentration of B cell epitopes.
We confirm that antibody enhancement of T depen-
dent humoral responses is mediated by activating
FcRs, likely by boosting the helper T cell component of
the follicular response. Interestingly, however IC-
mediated enhancement of humoral responses was
seen with both T independent and T dependent antigen
in g2/2 DCs (Figure 2), which lack the activating path-
way. Enhancement was due to persistence of FcgRIIB
expression rather than simple loss of the activating g
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511Figure 7. Antigen Processing Pathways Regulated by Activating (Green) versus Inhibitory Fc Receptors (Red)
ICs internalized by activating FcRs pathway are targeted for lysosomal degradation and entry into the exogenous pathway for MHC II and MHC I
loading. By coupling efficient antigen processing with ITAM-triggered induction of DC maturation, both CD4 and CD8 responses, are elicited. In
contrast FcgRIIB internalized ICs are inefficiently degraded and are not coupled with a maturation signal, blunting the potential for induction of T
cell mediated cellular immunity. Instead, FcgRIIB-internalized and cell surface recycled ICs promoting antigen-specific B cell activation.pathway as IC-enhanced responses were not seen in
FcgRg2/2, FcgRIIB2/2 doubly deficient animals (Figure
S2). Thus, the FcgRIIB-mediated retention/recycling
pathway could also promote both the activation of the
T dependent humoral response via both direct BCR-
mediated activation of specific B cells and by enabling
antigen delivery/transfer to B cells (Batista et al.,
2001), thereby promoting B cell-mediated Ag process-
ing/presentation during the B/T cell cognate interaction.
In the T independent response, myeloid-lineage ex-
pressed FcgRIIB could provide antigen trapping/preser-
vation/concentration functions in the extrafollicular
areas to promote high BCR/CD19/CD21 signaling. IC in-
ternalization through FcgRIIB leads to the retention of
a long-term reservoir of native antigen, a situation ex-
pected to be very different from free antigen. Cell-asso-
ciated antigen retained by migrating DCs would permit
delivery of limiting amounts of antigen to specific B
cell compartments in the context of DC-elaborated reg-
ulatory signals, including cytokines and TNF-family li-
gands. Further by concentrating antigen on the cell sur-
face, DC and B cell intercellular membrane interactions
(Batista et al., 2001) would be initiated and the overall
avidity of the BCR/CD19/CD21 receptor complex would
be enhanced. The presence of complement facilitated
class switching in vivo, suggesting that the additional
fixation of complement on ICs on the DC cell surface par-
ticipated in providing additional CD19/CD21-mediated
B cell signaling, necessary for class switch induction.
Thus, opsonization promotes antigenic uptake and re-
cycling by DCs, concentrating the antigen on DC mem-
branes for direct activation of B cells. Antibody enhance-
ment by FcgRIIB in antigen-experienced animals affords
the opportunity to directly amplify the B cell componentof ‘‘pure’’ and ‘‘mixed’’ T independent and T dependent
microbial and self-antigens.
Experimental Procedures
Mice
FcgR g2/2 and FcgRIIB2/2 (C57Bl/6 background) and FcgR2/2
FcgRIIB2/2 doubly deficient (C57Bl/6/129 background) were pur-
chased from Taconic Farms (Germantown, NY). Wt C57Bl/6 and
TCRbd2/2 mice were purchased from the Jackson Laboratory (Bar
Harbor, Maine). C32/2mice were a gift from Dr. Michael Carroll (Har-
vard Medical School, Cambridge, MA). RAG12/2 and RAG12/2
FcgRIIB2/2 BM chimeras were generated by i.v. transfer of 10 3
106 bone marrow cells from wt C57Bl/6 mice into RAG12/2
(C57Bl.6 N5) or FcgRIIB2/2 RAG12/2 irradiated recipients (300
RAD). Mice were immunized 12 weeks later upon hematopoetic re-
covery. B cell populations in these mice were 96% donor derived
whereas myeloid-derived peritoneal macrophages were 87% recip-
ient/13% donor-derived (Figure S3). All animal experiments were
performed in compliance with institutional guidelines and approved
by Columbia University’s IACUC committee.
Direct Immunization with T Independent Antigen
Mice were immunized i.p. with 10 mg of DNP-ficoll (Biosearch Tech-
nologies, Novato, CA) in PBS or with 10 mg of DNP-ficoll as a pre-
formed IC with 40 mL of heat inactivated IgG1 anti-DNP ascites
prepared from the hybridoma TIB191 (ATCC, Manassas, VA). DNP-
specific antibody titers were measured in serum collected on day
7. Five units of cobra venom factor (Calbiochem, San Diego, CA,
USA) were injected i.p. on days21, 0, and 3 to deplete complement
during immunization.
Primary Immunization with T Dependent and T Independent
Antigen Pulsed DCs
Day 7 BMDCs (prepared as in Rafiq et al. [2002]) were pulsed for
24 hr with OVA alone or OVA/ICs (5 mg:12.5 mg polyclonal rabbit
anti-OVA IgG per mL). DNP-ficoll ICs were formed using 20 mgs
per mL DNP-ficoll mixed with equal volume of hybridoma TIB191
anti-DNP supernatant. DCs were pulsed with DNP-ficoll ICs or an
Immunity
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injection antigen-pulsed DCs were collected using PBS 1 mM EDTA
and 1 3 106 cells were injected subcutaneously (OVA) or intrave-
nously (DNP-Ficoll) into recipient animals. Serum was collected on
day 7 and 14.
ELISAs
Maxisorp plates (Fisher Scientific, Pittsburgh, PA, USA) were coated
overnight at 4ºC with 10 mg/mL DNP-OVA or OVA in PBS and
blocked in PBS containing 0.25% pig gelatin (Sigma-Aldrich, St.
Louis, Missouri). Samples and standards were serially diluted in 50
ml PBS/block (1:100 to 1:2700) and 0.05% Tween and incubated
overnight on coated plates at 4ºC (single dilutions [1:100 for IgG3
and 1:2700 for IgM] are shown). Positive control sera were obtained
from mice immunized i.p. with OVA in TiterMax (Sigma-Aldrich) or
DNP-ficoll in PBS. Biotinylated antibodies to mouse IgM, IgG1 or
IgG3 were used (Southern Biotech, Birmingham, Alabama) followed
by avidin-HRP (BD Pharmingen, San Diego, CA, USA) and plates
read at OD450 after addition of peroxidase substrate A and B (BD
Pharmingen).
Immunoflourescence Endocytosis Assays
BMDCs were pulsed with OVA:polyclonal rabbit anti-OVA, and
biotin-OVA:anti-OVA at 10:50 mg/ml (nonprecipitating) on ice for 10
min, and washed and chased for indicated times at 37ºC. To detect
intracellular ICs, cells were fixed in 2% paraformaldehyde, per-
meabilized, and blocked with RPMI 10 mM glycine, 0.05% saponin
and 5% goat serum (Sigma) while extracellular ICs were detected
on fixed unpermeabilized cells. ICs were detected using anti-rabbit
IgG alexa-488 or avidin-alexa-594 (Molecular Probes, Eugene, OR).
The percentage of fluorescent cells was measured by counting 600
total cells in multiple representative fields. Each data point shows
the mean 6 SEM of triplicate determinations. In some experiments
DCs were preincubated with 20 mM chloroquine (Sigma) for 90 min
and maintained in chloroquine-containing medium throughout the
2 hr OVA-ICs pulse. Lysosomes were detected in permeabilized
cells using rat anti-LAMP-1 (BD Pharmingen) and anti-rat-alexa-
594 (Molecular Probes).
To study the effect of primaquine on IC recycling, g2/2 DCs were
pulsed with OVA-ICs, washed and then incubated in various doses
of primiquine (Sigma) during a 3 hr chase period. Surface ICs were
detected on fixed unpermeabilized DCs. To preserve cell viability,
DCs were incubated with 100 mM primiquine for only 1 hr before ad-
justing the concentration to 10 mM primiquine for the final 2 hr.
To determine internalization rates of ICs BMDCs were pulsed with
OVA-FITC (Molecular Probes)-containing ICs for 15, 60, or 120 min,
washed and fixed in 2% paraformaldehyde. The percent internaliza-
tion (internalized IC/total IC bound3 100) was calculated by dividing
the intracellular mean fluorescence intensity (MFI) in 250 mg/mL try-
pan blue (which quenches extracellular flourescence) at each time
point (internalized ICs) by the extracellular MFI at 4ºC in the absence
of trypan blue (total IC bound).
Cell imaging systems included the E500 fluorescent microscope
(Nikon Inc., Melville, NY) equipped with RT SPOT digital camera/
software package (Diagnostic Instruments, Sterling Heights, MI)
and a Zeiss LSM 510 meta scanning confocal with Zeiss digital im-
aging software (Zeiss, Thornwood, NY).
Antigen Presentation Assays to OT II Hybridomas
5 3 104 BMDCS were cultured with 2 3 105 OT II hybrids in 96-well
plates. T cell hybridomas from OT II mice were obtained after
screening (Malarkannan et al., 2001) of hybrids generated with the
BWZ.36 fusion partner (kindly provided by N. Shastri, University of
California, Berkeley, CA) (Sanderson and Shastri, 1994). Activation
of these T cell hybridomas induces b-galactosidase production,
measured spectrophotometrically by cleavage of chlorophenol
red-b-D-galactopyranoside (Calbiochem).
Cell-Based ELISA
BMDCs were pulsed overnight with OVA or OVA-ICs. Washed cells
were plated in 96-well flat-bottom plates, incubated at 37ºC for
1 hr, spun at 200 3 g for 10 min, fixed with 0.05% glutaraldehyde,
and blocked with 0.25% pig gelatin/PBS. To detect total cell-
associated OVA using rabbit anti-OVA conjugated to HRP (RDI.,Flanders, NJ), cells were first permeabilized with 0.1% Triton or in-
stead were left unpermeabilized to detect cell-surface bound OVA.
A standard OVA curve was generated from addition of soluble
OVA (0.1 to 100 ng/ml) to anti-OVA coated wells.
Immune Complex Recycling Assay
DCs were pulsed with biotin-OVA:anti-OVA ICs on ice and chased at
37ºC for 1 hr prior to stripping cell surface biotin with 200 mM
MESNA (Sigma). Intact biotin-OVA ICs that had recycled back to
the cell surface after 14 hr at 37ºC were detected with avidin-
alexa-594 (Molecular Probes).
DC:B Cell Coculture Studies
BMDCs were pulsed overnight with ICs made from goat anti-IgM
F(ab0)2 fragments (5 mg/ml) and rabbit anti-goat F(ab0)2 whole mole-
cule (30–50 mg/ml) (Jackson ImmunoResearch, West Grove, PA),
washed, and cocultured with B cells (CFSE-labeled (Molecular
Probes) CD43negative FcgRIIB2/2 splenocytes) at a ratio of 2:1
(B:DC) in round bottom 96-well plates with or without 2.5 mg/mL of
anti-CD40 (clone HM40, BD Pharmingen). CFSE dilution was mea-
sured on day 3 by flow cytometry. Conjugate formation was as-
sessed microscopically after coculture of IC pulse/washed DCs
and B cells on glass chamber slides for 20 min prior to washing
away free B cells or by flow cytometry (here conjugate formation oc-
curred in tubes).
Statistical Analysis
All analyses were performed using a two-tailed, unpaired Student’s
t test.
Supplemental Data
Supplemental Data include six figures and are available with this ar-
ticle online at http://www.immunity.com/cgi/content/full/23/5/503/
DC1/.
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